Trial intelligence / Profile preview

Remimazolam vs Propofol for Laryngeal Mask General Anesthesia in Elderly Undergoing Minimally Invasive Urological Surgery

ChiCTR2300076793Phase 4Not yet recruiting

Sponsor
The First Affiliated Hospital of Guangxi Medical University
Start
Oct 2023
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of remimazolam in None (3 arms), sponsored by The First Affiliated Hospital of Guangxi Medical University. Primary endpoint: Efficacy of anesthesia regimen. Planned start Oct 2023; status: not yet recruiting.

02

Drugs

remimazolam

Beyond the preview

Go deeper on ChiCTR2300076793.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2300076793.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call